Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Odontostomatol Trop ; 25(99): 5-13, 2002 Sep.
Article in French | MEDLINE | ID: mdl-12430348

ABSTRACT

Actually, there's an evolution of the periodontal treatment. Non surgical therapy is the main way of treatment today. Surgery takes place generally after non surgical therapy and reevaluation. The aim of this work is to compare these two treatments in relation with clinical parameters, to indicate the best therapy for the patient.


Subject(s)
Periodontal Diseases/surgery , Periodontal Diseases/therapy , Alveolar Bone Loss/surgery , Anti-Bacterial Agents/therapeutic use , Dental Research , Dental Scaling , Guided Tissue Regeneration, Periodontal , Humans , Oral Surgical Procedures , Periodontal Attachment Loss/pathology , Periodontal Attachment Loss/surgery , Periodontal Pocket/drug therapy , Periodontal Pocket/pathology , Periodontal Pocket/surgery
2.
Odontostomatol Trop ; 25(99): 33-7, 2002 Sep.
Article in French | MEDLINE | ID: mdl-12430354

ABSTRACT

In the periodontal treatment plane, non surgical therapy takes place a very important part. This treatment is easy to do and results are the same like surgery with less postoperative trauma and aesthetic damage. Although, non surgical therapy presents some limits as: depth of the pockets, radicular anatomy, instrumentation With these different clinical parameters, right indication and rational treatment plane can be used.


Subject(s)
Dental Scaling , Periodontal Diseases/therapy , Alveolar Bone Loss/pathology , Dental Plaque Index , Dental Scaling/instrumentation , Humans , Periodontal Pocket/pathology , Tooth Root/anatomy & histology , Ultrasonic Therapy
3.
J Periodontol ; 67(9): 927-34, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8884651

ABSTRACT

The purpose of this investigation was to test clinically the efficiency of a recently described bioabsorbable matrix as a guided tissue regeneration membrane. This matrix was prepared from an original reaction between elastin and fibrin monomers and is now extensively used in several domains of surgery. The study group was composed of 26 patients, with a total of 35 lesions (22 intrabony defects, 8 Class II furcations and 5 Class III furcations) presenting moderate to advanced adult periodontitis. After initial therapy, measurements were made with a calibrated periodontal probe. Probing depth (PD) and gingival margin location (GM) measurements were taken twice: immediately before surgery and after 6 months before re-entry. Clinical attachment level (CAL), vertical osseous level (VOL) and alveolar crest location (AC) measurements were taken during surgery and after 6 months with re-entry procedures for all the patients. Color change of the gingival margin was only observed in 4 defects and device exposure occurred in the proportion of 2 out of the 35 defects. No foreign body reaction was observed in any case. At the intrabony defects mean PD reduction was 5 mm (P < 0.001), and mean gain of CAL was 4 mm (P < 0.001). Mean VOL was 4.3 mm (P < 0.001), mean gingival recession was 0.9 mm (P < 0.05) and mean AC was 0.2 mm (NS). At the Class II furcation defects the mean PD reduction was 4.5 mm (P < 0.001), mean gain CAL vertical was 3.2 mm and CAL horizontal was 4.5 mm (P < 0.001). Gingival recession averaged 1 mm (NS). A complete closure was observed in 2 out of the 8 defects. At the Class III furcation defects the mean PD reduction was 3.6 mm (P < 0.05) and mean CAL-V gain was 1.5 mm (P < 0.02). However the 5 sites showed no horizontal attachment gain and none were unchanged. A very low gingival recession, gingival reaction, crestal bone loss, and device exposure occurred during this study. This preliminary study suggests that the use of a biosynthetic barrier may have beneficial effects in the treatment of intrabony defects and Class II furcation defects. Randomized controlled trials are necessary to evaluate the efficacy and safety of this bioabsorbable membrane in periodontal therapy.


Subject(s)
Alveolar Bone Loss/surgery , Elastin/chemistry , Fibrin/chemistry , Furcation Defects/surgery , Guided Tissue Regeneration, Periodontal/methods , Membranes, Artificial , Adult , Aged , Biocompatible Materials , Biodegradation, Environmental , Female , Humans , Male , Middle Aged
4.
J Biol Buccale ; 19(2): 173-84, 1991 Jun.
Article in French | MEDLINE | ID: mdl-1939041

ABSTRACT

12 patients (7 men and 5 women) with advanced periodontitis and probing depths of 4mm or more were selected to assess the effectiveness of an antiseptic: betadine used in situ, as a subgingival irrigation in periodontal pockets. Although widely used in other fields of medicine such as gynecology and dermatology, betadine has not been used in periodontology. However, betadine is an excellent antiseptic with a wide range of action. The slow release of iodine explains why this antiseptic is well tolerated by mucosae. The oral cavity was divided in 2 parts: the left side was irrigated with betadine while the right side was irrigated with saline which was used as a control. Irrigations were performed once a day during a period of 15 days. Patients were able to carry out the irrigations themselves after careful, instruction. Thc practitioner carried out the irrigation on day 0 and day 8. The comparison of clinical and histological data showed a decrease in gingival inflammation after 15 days of treatment. By means of the Student "t" test significant decreases in the plaque index, the gingival, index and the bleeding index were observed between day 0 and day 15 as well as a significant increase in recession. These clinical results were correlated with histological findings. Significant decreases in the volumetric density of the infiltrated connective tissue, the non collagenous structures and the number of plasma cells were observed as well as significant increases in the volumetric density of the non-infiltrated connective tissue of the collagenous structures and the number of fibroblasts.


Subject(s)
Gingivitis/drug therapy , Povidone-Iodine/therapeutic use , Administration, Topical , Adult , Connective Tissue/drug effects , Connective Tissue/pathology , Dental Plaque/drug therapy , Dental Plaque Index , Epithelium/drug effects , Epithelium/pathology , Female , Gingivitis/pathology , Humans , Male , Middle Aged , Periodontal Index , Periodontal Pocket/drug therapy , Periodontal Pocket/pathology , Periodontitis/drug therapy , Periodontitis/pathology , Povidone-Iodine/administration & dosage , Therapeutic Irrigation/instrumentation , Time Factors
5.
Odontostomatol Trop ; 13(3): 105-6, 1990 Sep.
Article in French | MEDLINE | ID: mdl-2075146

ABSTRACT

The aim of this article is to highlight the different ways of fighting against H.I.V. With AZT, using peptide T, the author has looked at the latest theories and research being undertaken and their respective successes. He reminds us that the AIDS vaccination is not to be found tomorrow.


Subject(s)
HIV Infections/therapy , Peptide T/therapeutic use , CD4 Antigens/immunology , Humans , Vaccination , Zidovudine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...